Rocket Pharmaceuticals, Inc. (RCKT)

Last Three Months

17-Feb-24 -- 16-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

3

(1)

16

0

3

+1

0

+2

0

+3

Two Year Chart

17-May-22 -- 16-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Mar-24 8:58 PM View:	21-Mar-24 Private Sale ($7.79M)	Makker Gotham Director		Rocket Pharmaceuticals, Inc. - RCKT	(43%) 639.91K to 365.91K	0	0	--	--	Show Txns Hide Txns

24-Apr-24 4:06 PM View:	22-Apr-24 Private Sale ($19.05K)	Militello John See Remarks		Rocket Pharmaceuticals, Inc. - RCKT	153% 21.52K to 54.41K	0	0	--	--	Show Txns Hide Txns

16-Apr-24 5:45 PM View:	15-Apr-24 Option Sale ($240.52K)	Southwell David P Director		Rocket Pharmaceuticals, Inc. - RCKT	21% 95.16K to 114.78K	0	0	--	--	Show Txns Hide Txns

04-Mar-24 6:48 PM View:	29-Feb-24 Private Sale ($120.26K)	Wilson Martin General Counsel		Rocket Pharmaceuticals, Inc. - RCKT	(18%) 22.78K to 18.68K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 6:02 PM View:	01-Apr-24 Grant 0	Ondrey Aaron Chief Financial Officer		Rocket Pharmaceuticals, Inc. - RCKT	100% 0 to 46.78K	0	0	--	--	Show Txns Hide Txns

10-Apr-24 8:39 PM View:	08-Apr-24 Private Sale ($308.76K)	White Mark Andrew See Remarks		Rocket Pharmaceuticals, Inc. - RCKT	(14%) 87.76K to 75.23K	0	0	--	--	Show Txns Hide Txns